home / stock / sbm / sbm news


SBM News and Press, ProShares Short Basic Materials From 06/28/23

Stock Information

Company Name: ProShares Short Basic Materials
Stock Symbol: SBM
Market: NYSE

Menu

SBM SBM Quote SBM Short SBM News SBM Articles SBM Message Board
Get SBM Alerts

News, Short Squeeze, Breakout and More Instantly...

SBM - Sirona Biochem Advances Antiviral Research with New Compound Candidates for Testing at the ICGEB

VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- June 28, 2023 – Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona ") is excited to announce the development of a promising new set of potential antiviral compounds which will undergo testing at the renowne...

SBM - Sirona Biochem Engages Atheln Inc. to Strengthen Business Development Initiatives

VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona ") is pleased to announce it has contracted Atheln Inc. (" Atheln "), a leading US consulting firm, to bolster and facilitate Sirona's business activities. Thi...

SBM - Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy

VANCOUVER, British Columbia, May 11, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) (“Sirona”) is pleased to announce that the Investing News Network has published an exclusive video interview with Dr. Geraldine Deliencourt-Godefroy, the Ch...

SBM - Sirona Biochem to Present Ground-breaking Anti-Aging Technology at BIO 2023 Conference in Boston

VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTCQB: SRBCF) (" Sirona ") is excited to announce that Dr. Geraldine Deliencourt-Godefroy, Chief Scientific Officer, will be presenting the Company's latest anti-aging technology, TFC-1...

SBM - Sirona Biochem Announces Exceptional Clinical Trial Results for Anti-Aging Compound TFC-1326

VANCOUVER, British Columbia, April 25, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona” ) is pleased to announce that the clinical trial results, for novel anti-aging compound TFC-1326, have exceeded even high expectations on key...

SBM - Sirona Biochem Announces Close of Oversubscribed Debenture Financing

VANCOUVER, British Columbia, April 20, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (Frankfurt: ZSB) (Xetra: ZSB) (the “ Company ”) announced today that it has closed an oversubscribed, non-brokered convertible debenture for gross proceeds of $1,563,600. The p...

SBM - Sirona Biochem Announces Debenture Financing

VANCOUVER, British Columbia, March 23, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ” or the “ Company ”) is pleased to announce a non-brokered private placement offering of unsecured, convertible debentures ...

SBM - Sirona Biochem Receives Antiviral Testing Results

VANCOUVER, British Columbia, Feb. 27, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) is pleased to announce it has received results from its research collaboration with the International Centre for Genetic Engineering and...

SBM - Sirona Biochem Announces the Termination of Supply Agreement with Rodan + Fields

VANCOUVER, British Columbia, Jan. 16, 2023 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“ Sirona ”) announces the termination of the Rodan + Fields (R+F) agreement for supply and use of TFC-1067 in commercial formulations. Allergan Aest...

SBM - ProShares Announces Changes to ETF Lineup

ProShare Advisors and ProShare Capital Management announced today plans to liquidate and close six ProShares Trust ETFs and two ProShares Trust II ETFs based on an ongoing review of ProShares product offerings. Specifically, the following ETFs will be liquidated and closed: The last...

Previous 10 Next 10